approval
saveGLEEVEC (IMATINIB MESYLATE) — FDA approval
community read0 votes
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalGLEEVEC (IMATINIB MESYLATE) — FDA approvalJan 14, 2026 · 263d ago
- approvalGLEEVEC (IMATINIB MESYLATE) — FDA approvalMar 1, 2024 · 947d ago
- approvalGLEEVEC (IMATINIB MESYLATE) — FDA approvalMar 24, 2022 · 1655d ago
- approvalGLEEVEC (IMATINIB MESYLATE) — FDA approvalAug 10, 2020 · 2246d ago
- approvalGLEEVEC (IMATINIB MESYLATE) — FDA approvalAug 10, 2020 · 2246d ago
- approvalGLEEVEC (IMATINIB MESYLATE) — FDA approvalAug 21, 2018 · 2966d ago
- approvalGLEEVEC (IMATINIB MESYLATE) — FDA approvalSep 29, 2017 · 3292d ago
- approvalGLEEVEC (IMATINIB MESYLATE) — FDA approvalSep 6, 2017 · 3315d ago
same company · ±60 days · 4
- approvalKESIMPTA: KESIMPTA (OFATUMUMAB) — FDA approvalSep 2, 2022
- approvalasciminib hydrochloride: SCEMBLIX (ASCIMINIB HYDROCHLORIDE) — FDA approvalOct 12, 2022
- approvalSpexotras: MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approvalJun 22, 2022
- approvaldabrafenib mesylate ODT: TAFINLAR (DABRAFENIB MESYLATE) — FDA approvalJun 22, 2022
comments(0)
5-min edit window · permanent after that